GRANT GT011- Phase 2 Clinical Study for Wave Gene Therapy Product

Status	Finished
Effective start/end date	1/04/11 → 31/05/11

The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep
Alton, E. W., Baker, A., Baker, E., Boyd, C., Cheng, S. H., Coles, R., Collie, D., Davidson, H., Davies, J. C., Gill, D. R., Gordon, C., Griesenbach, U., Higgins, T., Hyde, S. C., Innes, J. A., McCormick, D., McGovern, M., McLachlan, G., Porteous, D., Pringle, I. A., & 6 othersScheule, R. K., Shaw, D., Smith, S., Summer-Jones, S., Tennant, P. & Vrettou, C., 2013, In: Biomaterials. 34, 38, p. 10267-10277
Research output: Contribution to journal › Article › peer-review

Open Access
File
Validation of recombinant Sendai virus in a non-natural host model
Griesenbach, U., McLachlan, G., Owaki, T., Somerton, L., Shu, T., Baker, A., Tennant, P., Gordon, C., Vrettou, C., Baker, E., Collie, D. D. S., Hasegawa, M. & Alton, E. W. F. W., Feb 2011, In: Gene Therapy. 18, 2, p. 182-188 7 p.
Research output: Contribution to journal › Article › peer-review

British Science Week
Gerry McLachlan (Lecturer)
14 Mar 2016
Activity: Participating in or organising an event types › Public Engagement – Festival/Exhibition
University of Glasgow Seminar: Gene Therapy for CF - Time to Deliver.
Gerry McLachlan (Speaker)
15 Oct 2015
Activity: Academic talk or presentation types › Invited talk
Peebles Mini-Science Event Public Lecture
Gerry McLachlan (Lecturer)
1 Oct 2014
Activity: Participating in or organising an event types › Public Engagement – Public lecture/debate/seminar

Project Details